↓ Skip to main content

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis

Overview of attention for article published in Frontiers in Pharmacology, January 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
26 Mendeley